Author

T. Lonnberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Jerez· 1 shared A. Kokko· 1 shared A. Kreutzman· 1 shared A. M. Hurtado· 1 shared A. Malyukova· 1 shared C. Munoz-Calleja· 1 shared D. Kim· 1 shared G. Park· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Jerez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1 positive pediatric leukemia identifies drug-targetable transcription factor activities

J. Mehtonen, S. Teppo, M. Lahnalampi, A. Kokko, R. Kaukonen, L. Oksa, M. Bouvy-Liivrand, A. Malyukova, S. Laukkanen, P. I. Makinen, S. Rounioja, P. Ruusuvuori, O. Sangfelt, R. Lund, T. Lonnberg, , M. Heinaniemi

This study uses scRNA-seq to analyze B-lymphoid differentiation and leukemic cell states in ETV6-RUNX1-positive pediatric leukemia, identifying drug-targetable transcription factor activities.

bioRxiv · May 27, 2020Cancer Biology

Somatic Mutations in Clonally Expanded T-lymphocytes in Patients with Chronic Graft-Versus-Host Disease

G. Park, S. Mustjoki, D. Kim, J. Huuhtanen, S. Lundgren, R. K. Khajuria, A. M. Hurtado, C. Munoz-Calleja, L. Cardenoso, V. Gomez-Garcia de Soria, T. H. Chen-Liang, S. Eldfors, P. Ellonen, S. Hannula, O. Bruck, , M. A. I. Keranen

This study identifies somatic mutations in clonally expanded T-cells in chronic GvHD patients, showing they drive persistent activation and resistance to mTOR inhibitors.

bioRxiv · Aug 31, 2019 · PreprintImmunology